Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
Use this FATE page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FATE quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FATE SEC filings page. Lician reads the product cache first so this HTML stays unique to Fate Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full FATE income, balance, and cash tables.